Jordan JT - Search Results

1

Jordan JT, Plotkin SR. Jordan JT, et al. Hematol Oncol Clin North Am. 2022 Feb;36(1):253-267. doi: 10.1016/j.hoc.2021.08.010. Epub 2021 Oct 27. Hematol Oncol Clin North Am. 2022. PMID: 34756486 Review.

2

Teaching NeuroImages: brain mass with hilar adenopathy: the importance of histologic diagnosis.

Jordan JT, Yang HS, Narendra D, Plotkin SR. Jordan JT, et al. Neurology. 2014 May 6;82(18):e161-2. doi: 10.1212/WNL.0000000000000393. Neurology. 2014. PMID: 24799521

3

Magnetic resonance imaging observations in primary central nervous system lymphoma.

Jordan JT, Plotkin S, Dietrich J. Jordan JT, et al. JAMA Neurol. 2014 Jul 1;71(7):918-9. doi: 10.1001/jamaneurol.2014.70. JAMA Neurol. 2014. PMID: 24861724 No abstract available.

4

A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.

Beauchamp RL, James MF, DeSouza PA, Wagh V, Zhao WN, Jordan JT, Stemmer-Rachamimov A, Plotkin SR, Gusella JF, Haggarty SJ, Ramesh V. Beauchamp RL, et al. Among authors: jordan jt. Oncotarget. 2015 Jul 10;6(19):16981-97. doi: 10.18632/oncotarget.4858. Oncotarget. 2015. PMID: 26219339 Free PMC article.

5

Glioblastoma care in the elderly.

Jordan JT, Gerstner ER, Batchelor TT, Cahill DP, Plotkin SR. Jordan JT, et al. Cancer. 2016 Jan 15;122(2):189-97. doi: 10.1002/cncr.29742. Epub 2015 Nov 30. Cancer. 2016. PMID: 26618888 Free article. Review.

6

Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1: Population-Based Approach.

Terry AR, Jordan JT, Schwamm L, Plotkin SR. Terry AR, et al. Among authors: jordan jt. Stroke. 2016 Jan;47(1):60-5. doi: 10.1161/STROKEAHA.115.011406. Epub 2015 Dec 8. Stroke. 2016. PMID: 26645253

7

Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention.

Walsh KS, Janusz J, Wolters PL, Martin S, Klein-Tasman BP, Toledo-Tamula MA, Thompson HL, Payne JM, Hardy KK, de Blank P, Semerjian C, Gray LS, Solomon SE, Ullrich N; REiNS International Collaboration. Walsh KS, et al. Neurology. 2016 Aug 16;87(7 Suppl 1):S21-30. doi: 10.1212/WNL.0000000000002928. Neurology. 2016. PMID: 27527646 Free PMC article.

8

Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis.

Ahlawat S, Fayad LM, Khan MS, Bredella MA, Harris GJ, Evans DG, Farschtschi S, Jacobs MA, Chhabra A, Salamon JM, Wenzel R, Mautner VF, Dombi E, Cai W, Plotkin SR, Blakeley JO; Whole Body MRI Committee for the REiNS International Collaboration; REiNS International Collaboration Members 2016. Ahlawat S, et al. Neurology. 2016 Aug 16;87(7 Suppl 1):S31-9. doi: 10.1212/WNL.0000000000002929. Neurology. 2016. PMID: 27527647 Free PMC article.

9

Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.

Wolters PL, Martin S, Merker VL, Tonsgard JH, Solomon SE, Baldwin A, Bergner AL, Walsh K, Thompson HL, Gardner KL, Hingtgen CM, Schorry E, Dudley WN, Franklin B; REiNS International Collaboration. Wolters PL, et al. Neurology. 2016 Aug 16;87(7 Suppl 1):S4-S12. doi: 10.1212/WNL.0000000000002927. Neurology. 2016. PMID: 27527648 Free PMC article.

10

Creation of an international registry to support discovery in schwannomatosis.

Ostrow KL, Bergner AL, Blakeley J, Evans DG, Ferner R, Friedman JM, Harris GJ, Jordan JT, Korf B, Langmead S, Leschziner G, Mautner V, Merker VL, Papi L, Plotkin SR, Slopis JM, Smith MJ, Stemmer-Rachamimov A, Yohay K, Belzberg AJ. Ostrow KL, et al. Among authors: jordan jt. Am J Med Genet A. 2017 Feb;173(2):407-413. doi: 10.1002/ajmg.a.38024. Epub 2016 Oct 19. Am J Med Genet A. 2017. PMID: 27759912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

129 results

Search Page